Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jolanda Howe
16 Oct 2026
SVP, Global Controller
Exercised, kept
16,112
$19.24
$309.99K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
6,892
$15.87
$109.38K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
5,305
$19.19
$101.80K
Eric Bjerkholt
9 Jun 2026
Chief Financial Officer
Exercised, kept
2,393
$26.49
$63.39K
Peter Radovich
5 Jun 2026
President and COO
Exercised, kept
16,988
$19.19
$326.00K
Peter Radovich
6 Mar 2026
President and COO
Exercised, kept
5,912
$15.87
$93.82K
Christopher Peetz
18 Nov 2025
Chief Executive Officer
Exercised, kept
19,133
$19.24
$368.12K
Eric Bjerkholt
12 Aug 2025
Chief Financial Officer
Exercised, kept
2,954
$26.49
$78.25K
Christopher Peetz
23 Jul 2024
Chief Executive Officer
Exercised, kept
34,013
$2.94
$99.86K
Edwin Jonathan Tucker
5 Mar 2021
Chief Medical Officer
Exercised, kept
1,082
$7.70
$8.33K
Edwin Jonathan Tucker
28 Dec 2020
Chief Medical Officer
Exercised, kept
4,167
$7.70
$32.09K
Edwin Jonathan Tucker
30 Oct 2020
Chief Medical Officer
Exercised, kept
25,000
$7.70
$192.50K

What was left out

Form 4 filings counted 314
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 49
Sales at will 79
Transactions with no price 2
Shares from compensation/vesting 77,812,862
Sales filed before the plan box existed 19
History held since 18 Jul 2019